Soft Gel Technologies, Inc.® To Introduce a New Cardiovascular Formula Containing PomElla® Pomegranate Extract at SupplySide West

LOS ANGELES, CA, September 25, 2006—Soft Gel Technologies, Inc.® (SGTI) and Geni Herbs have aligned to launch a comprehensive, new heart-health product containing PomElla® natural-spectrum pomegranate extract, tocotrienols, mixed tocopherols, and marine lipids. PomElla® soft gels will be introduced in October at the SupplySide West trade show in Las Vegas, NV. Exclusively available from SGTI, PomElla® soft gels are standardized to contain pomegranate’s most powerful antioxidant, punicalagins, but still maintain the same ratio of polyphenols from whole pomegranate. More information about supplementation with PomElla® will be explained by Susanne Mertens-Talcott, Ph.D. during a VendorWorks presentation at SupplySide West on Friday, October 20th from 12:30-1:20 p.m. on the Exhibit Hall Floor, Booth #7083. In her talk entitled, “New Research on PomElla®: Absorption, Metabolism, and Antioxidant Effects,” Dr. Mertens-Talcott will discuss new findings on PomElla® and the benefits of supplementing the diet with the rich antioxidants found in PomElla® natural-spectrum pomegranate extract.

Dr. Mertens-Talcott was formerly a research associate at the University of Florida and is now with Texas A&M University. Her primary focus of research includes the study of phytochemicals in the prevention of chronic disease. In cooperation with Geni Herbs, Soft Gel Technologies, Inc.® will provide free literature and samples of PomElla® soft gels, the exclusive soft gel encapsulation of PomElla® brand pomegranate extract, to seminar participants.

PomElla® is Geni Herbs’ clinically-studied, organically-grown, and GMO-free natural-spectrum pomegranate extract. It contains a similar profile of polyphenolic compounds as unpasteurized pomegranate juice concentrate studied in clinical research, without any of the sugar, calories, or additives. Geni Herbs is the only supplier that offers this proprietary ellagitannin complex standardized to punicalagins. PomElla® soft gels are formulated with 300 mg PomElla® pomegranate extract, 250 mg of fish oil (providing omega-3 fatty acids), and 11.5 mg tocotrienols and mixed tocopherols. Two soft gels daily provide a synergistic mix of beneficial compounds that enhance cardiovascular health.

SGTI® President, Ron Udell, remarked, “Our affiliation with Geni Herbs provides us the opportunity to manufacture a recognized, branded ingredient in soft gels. Joining forces to co-promote this new product is mutually beneficial and helps us reach a larger audience.” Mr. Udell added, “PomElla® soft gels are a great addition to any cardiovascular product line.”

About Soft Gel Technologies, Inc.®
Soft Gel Technologies, Inc.® is a leading contract manufacturer providing specialty soft gelatin encapsulation to the nutraceutical industry. SGTI’s leading product is a patented highly bioavailable CoQ10 soft gel marketed as CoQsol®. Other key products include GlucoFit®, a banaba leaf extract for blood glucose management and Injuv®, a low molecular weight hyaluronic acid for cosmeceutical and joint health applications. Soft Gel Technologies, Inc.® is a privately held company based in Los Angeles, CA.

For more information, visit


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.